Interpace Diagnostics: Jumps after health insurer covers co's cancer tests
20/06/2019 12:38
** Cancer diagnostics co's shares IDXG.O rise 18.6% to 83
cents
** Stock set to erase YTD losses, if gains hold
** Co says two of its tests for thyroid cancer are now
covered by health insurer Independence Blue Cross, which has
nearly 2.5 mln enrollments in Philadelphia and Southeastern
Pennsylvania urn:newsml:reuters.com:*:nGNX248f8r
** IDXG says Independence members and their physicians now
have a cost-effective access to co's services
** IDXG says the tests, ThyGeNEXT and ThyraMIR, are also
covered by Medicare and a growing list of commercial insurers
(Reporting by Manas Mishra in Bengaluru)
((Reuters Messaging:
manas.mishra.thomsonreuters.com@reuters.net))